New to site?


Login

Lost password? (X)

Already have an account?


Signup

(X)

28 Feb 2019

9th World Congress of Diabetes

-21Days -12Hours -14Minutes -35Seconds
HomeScientific Highlights

[ Scientific Highlights ]

Plenary Talks

  • Newer aspects of Type 2 DM Pathology
  • Type 2 Diabetes Prevention: How to turn back the Clock & Change the Future?
  • Is diabetes an inflammatory disease?
  • Beyond A1c – New Outcomes for Diabetes
  • Hypoglycaemia and vascular complications
  • Multifactorial Approach to Type 2 Diabetes – Weight, BP and Lipids
  • Diabetic Destiny – Pre-Life Exposure
  • Sugar Coated Neurology: the sweet truth
  • Reaching Composites Targets (HbA1c + SBP + LDC-C) in T2DM
  • Fatty Liver Disease Impact on Diabetic Population
  • Association of Time in Range, as Assessed by Continuous Glucose Monitoring
  • Shaping the Future: New Agents for Glucose Control
  • Atherogenic Dyslipidaemia in Diabetes: What should the Clinician Do?
  • Why are Remnant Particles of TRLs (Triglyceride Rich Lipoproteins) – The Killer in Diabetes?
  • A Combination Approach: Targeting multiple defects of Diabetes
  • Stem Cells as a Bio-Marker for Diabetes Medications
  • Heart Failure: The often-forgotten Diabetes Complication
  • Physiological Basis of Diabetes Therapies… and what we can learn from it
  • Pre-Diabetes: Facts & Medication Guidance

Basic Science

  • Evolution of Classification of DM: Glucose homeostasis and Beta Cell dysfunction in Indian DM
  • Ageing Obesity & Diabetes: Molecular Connections & Clinical Implications
  • Behind Insulin Resistance: Debugging the Endocrine System
  • Amazing Science of Physical Exercise in Diabetes: Lessons learned so far
  • Genome & Environment: Two Side Conspiracy in the Evolution towards Diabetes
  • Recent Understanding on Glucagon – A Complex Hormone
  • Glucocrinology – Pituitary, Thyroid, Parathyroid and Adrenals
  • Bile Acid Regulation in Glucose Homeostasis
  • Recent Advancement in the Alpha Cell and Beta Cells

Guidelines & Consensus

  • The 2018 ADA/EASD Consensus report – Implications for Management of Type 2 Diabetes
  • From CAEMELINA to HARMONY and beyond: How to the CVOT’s help us?
  • CVOTS, their role and relevance in clinical Practice
  • SGLT2i: From BIG data to Clinical Application
  • How guidelines influence clinical management in Type 2 Diabetes
  • Bridging the Gap between Clinical Trials & Clinical Practice in Type 2 Diabetes
  • Glycaemic Control & beyond: Shifting the paradigm in Diabetes Care
  • Early optimization of Cardio Metabolic Legacy in T2DM: lessons Post EMPA REG OUTCOME
  • Life after DECLARE – A Changing lens for the Patients
  • Updates on the outcome trials of Canagliflozin
  • CVOT with Gliptins – What does Latest Evidence Say?
  • Initiating Real World Evidence – Key findings from INITIAL Study

Complications

  • Novel Markers for Screening Diabetes Complications
  • Role of Physician in Managing Early Stage Diabetic Nephropathy
  • Recent Trends in Diabetic Kidney Disease
  • Kidney & CVD in Diabetes: Two side of the same coin?
  • How to delay the Progression of Diabetic Nephropathy?
  • Sugar Control in Patients with Renal Dysglycemia

Clinical Insights

  • C. Peptide – Physiology to Clinical Use
  • Novel Therapies for NASH
  • Traditional Risk Factors of Diabetes: Can they Explain the Epidemics of Diabetes?
  • Benedict’s Reagent to Precision Medicine in Diabetes: Are we at Cross Roads?
  • Individualized Diabetes Care Across the Edge
  • Point of Care in Diabetes Management
  • Therapeutic Lifestyle Modification: Seed of the Hour
  • Does Glycaemic Variability really matter?

Diabetes & Women

  • Adolescent females with PCOS
  • CV risk in Women with Diabetes
  • Post-menopausal women with diabetes
  • Differentiating Pre GDM-from GDM
  • Managing a patient of Gestational Diabetes Mellitus
  • Hyperglycaemia in the first trimester – why and how to prevent it?

Obesity

  • Diabesity: The recent Concern
  • Weight Management in Clinical Practice
  • Novel Anti-Obesity Drugs
  • Mechanism for Cure of Diabetes by Metabolic Surgery

Nutrition

  • High Protein Diet v/s Low Carbohydrate Diet: Which is better?
  • Artificial Sweeteners in Diabetes: How Safe?
  • VLCD – Ketogenic Diet: Is it safe in Health & Diabetes?
  • Fruits in Diabetes: Myths & Realities
  • Modification of Dietary Fats by Education on Nutrition in Schools & Training Physicians

Therapeutic

  • Metformin and the Gut: New Actions for an Old Drug
  • Do SU Still have a Place in our Clinical Practice?
  • Glitazone – Back from the Ashes
  • Antiglycaemic Medication: What is in the Pipeline?
  • Comparison of SGLT2i and GLP-1 for Vascular & Heart Health
  • Newer AMPK Kinase Activator in the Management of Diabetes

Paediatric Diabetes

  • Type 1 Diabetes: Unmet Need & Future Directions
  • Use of technology in Treatment of Type 1 Diabetes
  • Latest Advances in Paediatric Diabetes
  • Classification of Diabetes – 50 shades of grey: Type 1.5 (Flatbush), LADA, Type 3, Pancreatic
  • Long-term complications of diabetes in youths
  • Coping up with the diagnosis of type 1 DM – Insulin Motivation and Insulin Emotions
  • Improving Glucose Control in Type 1 Diabetes
  • Do We need to have a Paradigm Shift in Type 1 Diabetes Management?
  • Decision support tools for T1D patients: First to Patients v/s First to Physicians

Neglected Complications

  • Diabetes and Pulmonary Koch’s – A Deadly Combination
  • Peculiar Infections in Diabetes
  • OSA and Diabetes Link
  • Lipodystrophy: Congenital & Acquired
  • Asymptomatic Hyperuricemia: To Treat or Not
  • Approach to Asymptomatic Bacteriuria in Diabetes
  • Diabetes & NAFLD
  • Diabetes & Cancer
  • Diabetes & Bones
  • Periodontitis in Diabetes
  • Hypogonadism and Type 2 DM
  • Managing Erectile Dysfunction with Normal Sex Hormones

Debates / Controversies

  • Is prandial Insulin Dead in T2D?
  • Is Insulin still the best injectable therapy?
  • CVOT Trials in Diabetes: Should our management be dependent on these?
  • Should SGLT2i be considered drugs for cardiologists?
  • Should We use HbA1c for Diagnosis of Diabetes?
  • Is bariatric surgery justified in childhood obesity?

Symposium

  • IDF – Diabetic Foot Symposium
  • CODHY Symposium on Controversies in Diabetes
  • ATTD Technology Symposium
  • Diabetes Reversal Symposium
  • Metabolic Surgery Symposium

Workshops

  • Insulin Pump Workshop
  • Research Methodology Workshop
  • Medical Writing Workshop
  • Insulin Workshop
  • Monitoring Workshop
  • Educator’s Workshop

Meet the Experts

  • Diabetes in Young
  • Diabetes Management in Resource Constrained Setting
  • Setting up a Diabetes Care Centre
  • Use of Various Guidelines in Clinical Practice

Diabetes Premier League